NasdaqCM - Nasdaq Real Time Price USD

180 Life Sciences Corp. (ATNFW)

0.0077

+0.0002

+(2.67%)

As of 10:13:09 AM EDT. Market Open.

180 Life Sciences Corp. Announces Notice of Allowance for U.S. Patent Covering Novel Method to Prevent or Reduce Post-Operative Cognitive Dysfunction

PALO ALTO, CA / ACCESS Newswire / May 1, 2025 / 180 Life Sciences Corp. (NASDAQ:ATNF) ("180 Life Sciences" or the "Company"), an innovative media and entertainment company focused on the global iGaming sector, with certain legacy biotechnology intellectual ...

ACCESS Newswire 21 days ago

ATNF

ATNFW
+2.67%
180 Life Sciences Corp. Announces Share Repurchase

PALO ALTO, CALIFORNIA / ACCESS Newswire / April 30, 2025 / 180 Life Sciences Corp. (NASDAQ:ATNF) ("180 Life Sciences," the "Company," "we," or "us") today announced that it has entered into a Settlement and Mutual Release Agreement (the "Agreement") ...

ACCESS Newswire 22 days ago

ATNF

ATNFW
+2.67%
180 Life Sciences Corp. Announces Pricing of $2.9 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market Under NASDAQ Rules

PALO ALTO, CALIFORNIA / ACCESSWIRE / December 27, 2024 / 180 Life Sciences Corp. ("180" or the "Company") (NASDAQ:ATNF), a biotechnology company that is currently refocusing its business on the international entertainment and iGaming sector, today ...

ACCESS Newswire 4 months ago

ATNF

ATNFW
+2.67%
180 Life Sciences Corp. Regains Full Compliance with Nasdaq Continued Listing Rules

PALO ALTO, CA / ACCESSWIRE / December 12, 2024 / 180 Life Sciences Corp. ("180" or the "Company") is pleased to announce that it has regained compliance with Nasdaq Listing Rule 5605(c)(2), which requires Nasdaq listed companies to maintain an audit ...

ACCESS Newswire 5 months ago

ATNF

ATNFW
+2.67%
180 Life Sciences Corp. Announces the Appointment of Stephen Shoemaker to Board of Directors

PALO ALTO, CA / ACCESSWIRE / December 4, 2024 / 180 Life Sciences Corp. ("180" or the "Company") (NASDAQ:ATNF), a biotechnology company that is currently refocusing its business on the international entertainment and iGaming sector, today announced ...

ACCESS Newswire 5 months ago

ATNF

ATNFW
+2.67%
180 Life Sciences Corp. Retains Senior Technology Consultant and Commences Gaming Technology Platform Integration

PALO ALTO, CA / ACCESSWIRE / October 31, 2024 / 180 Life Sciences Corp. ("180" or the "Company") (NASDAQ:ATNF) today announced the retention of Mr. Vaclav Vincalek as Senior Technology Consultant. An accomplished technologist with a strong record ...

ACCESS Newswire 6 months ago

ATNF

ATNFW
+2.67%
180 Life Sciences Corp. Appoints Mr. Jay Goodman to Board of Directors

PALO ALTO, CA / ACCESSWIRE / October 29, 2024 / 180 Life Sciences Corp. ("180" or the "Company") (NASDAQ:ATNF) today announced the appointment of Mr. Jay Goodman to its Board of Directors, effective immediately. Mr. Goodman brings over a decade of ...

ACCESS Newswire 6 months ago

ATNF

ATNFW
+2.67%
Elray Resources Announces Strategic Sale of Crypto iGaming Technology

LAS VEGAS, Oct. 25, 2024 (GLOBE NEWSWIRE) -- Elray Resources Inc. (OTCPK:ELRA) is pleased to announce a significant milestone in the company’s growth strategy. Elray has completed the sale of proprietary technology to 180 Life Sciences Corp. (NASDAQ:ATNF), a NASDAQ-listed company in exchange for preferred stock convertible into a 40% stake in ATNF and warrants to purchase 3 million shares of ATNF common stock, the conversion/exercise of which is subject to stockholder approval. The technology st

GlobeNewswire 6 months ago

ELRA

ATNF

ATNFW
+2.67%
180 Life Sciences' Brave Decision To Switch to the iGaming Industry

Stock Price Jumps over 325.66% as Investors Welcome New Strategy

GuruFocus.com 7 months ago

ATNF

ATNFW
+2.67%
180 Life Sciences Corp. Interim CEO, Blair Jordan, Issues Letter to Stockholders; Provides Update on Newly Acquired Gaming Technology Platform

PALO ALTO, CA / ACCESSWIRE / October 16, 2024 / 180 Life Sciences Corp. (NASDAQ:ATNF)("180" or the "Company"), today released the following letter to stockholders from its Interim Chief Executive Officer, Blair Jordan. Dear Stockholders: We are excited ...

ACCESS Newswire 7 months ago

ATNF

ATNFW
+2.67%
180 Life Sciences Corp. Regains Compliance with Nasdaq's Minimum Stockholders' Equity Rule and Expands into the Global iGaming Sector

PALO ALTO, CA / ACCESSWIRE / October 9, 2024 / 180 Life Sciences Corp. (NASDAQ:ATNF) (the "Company" or "180"), is pleased to announce that it has received confirmation from Nasdaq that the Company has officially regained compliance with Nasdaq Listing ...

ACCESS Newswire 7 months ago

ATNF

ATNFW
+2.67%
180 Life Sciences Corp. - Corporate Updates

Announcing Acquisition of Advanced Gaming Technology Platform, Positive Progress on Legacy CBD Formulation, and Strengthened Balance Sheet PALO ALTO, CA / ACCESSWIRE / October 3, 2024 / 180 Life Sciences Corp. (NASDAQ:ATNF) (the "Company" or "180") ...

ACCESS Newswire 7 months ago

ATNF

ATNFW
+2.67%
180 Life Sciences Announces the Appointment of Omar Jimenez as Chief Financial Officer

PALO ALTO, Calif., Sept. 12, 2024 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (“180” or the “Company”) is pleased to announce the appointment of Omar Jimenez as its new Chief Financial Officer, effective September 30, 2024. Mr. Jimenez, already a director of the Company, will play a key role in driving the financial strategy of the Company as it continues to grow and innovate in the pharma and biotechnology sectors. "We are excited to have Omar stepping onto our executive team," said Mr. Blair J

GlobeNewswire 8 months ago

ATNF

ATNFW
+2.67%
180 Life Sciences Announces Positive Topline Results of a Clinical Pharmacology Study Testing a New Solid Formulation of CBD with Enhanced Oral Uptake

PALO ALTO, Calif., July 30, 2024 (GLOBE NEWSWIRE) -- PALO ALTO, Calif., July 30, 2024 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ: ATNF) (“180 Life Sciences” or the “Company”), today announced topline results from a clinical pharmacology study (the “Study”), that evaluated the uptake of cannabidiol (CBD) in a solid formulation which can be delivered as a pill orally. The clinical trial in humans, performed with Prof. Avi Domb of the Hebrew University, School of Pharmacy, and with Prof. E

GlobeNewswire 9 months ago

ATNF

ATNFW
+2.67%
180 Life Sciences Granted an Additional Extension by Nasdaq Hearing Panel to Regain Compliance with Continued Listing Requirements

PALO ALTO, Calif., July 23, 2024 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ: ATNF) (“180 Life Sciences” or the “Company”), today announced that it received notice from the Nasdaq Listing Qualifications Panel (the “Hearings Panel”) of The Nasdaq Stock Market LLC (“Nasdaq”) that the Hearings Panel has granted the Company’s request for additional time to achieve compliance with Nasdaq’s continued listing rules and demonstrate long-term compliance with the Equity Rule (defined below). Speci

GlobeNewswire 9 months ago

ATNF

ATNFW
+2.67%
180 Life Sciences Granted Extension by Nasdaq Hearing Panel to Regain Compliance with Continued Listing Requirements

PALO ALTO, Calif., July 02, 2024 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ: ATNF) (“180 Life Sciences” or the “Company”), today announced that it received notice from the Nasdaq Listing Qualifications Panel (the “Hearings Panel”) of The Nasdaq Stock Market LLC (“Nasdaq”) that the Hearings Panel has determined to grant the Company’s request to continue its listing on The Nasdaq Stock Market, subject to the Company meeting certain conditions, including filing on or before July 31, 2024,

GlobeNewswire 10 months ago

ATNF

ATNFW
+2.67%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

180 Life Sciences Corp. (ATNFW)

180 Life Sciences Corp. Announces Notice of Allowance for U.S. Patent Covering Novel Method to Prevent or Reduce Post-Operative Cognitive Dysfunction

180 Life Sciences Corp. Announces Share Repurchase

180 Life Sciences Corp. Announces Pricing of $2.9 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market Under NASDAQ Rules

180 Life Sciences Corp. Regains Full Compliance with Nasdaq Continued Listing Rules

180 Life Sciences Corp. Announces the Appointment of Stephen Shoemaker to Board of Directors

180 Life Sciences Corp. Retains Senior Technology Consultant and Commences Gaming Technology Platform Integration

180 Life Sciences Corp. Appoints Mr. Jay Goodman to Board of Directors

Elray Resources Announces Strategic Sale of Crypto iGaming Technology

180 Life Sciences' Brave Decision To Switch to the iGaming Industry

180 Life Sciences Corp. Interim CEO, Blair Jordan, Issues Letter to Stockholders; Provides Update on Newly Acquired Gaming Technology Platform

180 Life Sciences Corp. Regains Compliance with Nasdaq's Minimum Stockholders' Equity Rule and Expands into the Global iGaming Sector

180 Life Sciences Corp. - Corporate Updates

180 Life Sciences Announces the Appointment of Omar Jimenez as Chief Financial Officer

180 Life Sciences Announces Positive Topline Results of a Clinical Pharmacology Study Testing a New Solid Formulation of CBD with Enhanced Oral Uptake

180 Life Sciences Granted an Additional Extension by Nasdaq Hearing Panel to Regain Compliance with Continued Listing Requirements

180 Life Sciences Granted Extension by Nasdaq Hearing Panel to Regain Compliance with Continued Listing Requirements